Funded Tech Companies
Addex Therapeutics
Headquartered in Geneva, Addex Therapeutics has funding from private investors.
Company Overview
Company Name
Addex Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Chemin des Mines, 9
Geneva, CH-1202
CH
Geneva, CH-1202
CH
Phone
Website
Email Address
Company Background Information
Overview
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available, small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional, non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, ADX71149 (mGlu2 positive allosteric modulator or PAM), developed in collaboration with Janssen Pharmaceuticals, Inc., is in a Phase 2a proof of concept clinical trial for the treatment of epilepsy.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/4/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Dyer
Chief Medical Officer
Roger Mills
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs